Filing Flows › Amarin (AMRN) › Q2 2026 › vs Q2 2025
Amarin (AMRN) Q2 2026 vs Q2 2025 (year over year)
Amarin's revenue fell $30.5M (-42%) from $72.7M in Q2 2025 to $42.2M in Q2 2026. The biggest changes: Licensing and Royalty −$23.0M (-88%); Product −$7.5M (-16%).
Amarin, Q2 2026: revenue $42.2M (-42% year over year), operating margin -28.5%, net loss $7.7M, operating cash flow $6.6M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product | $39.1M | $46.6M | −$7.5M | -16% |
| Licensing and Royalty | $3.1M | $26.1M | −$23.0M | -88% |
| Revenue | $42.2M | $72.7M | −$30.5M | -42% |
| Other income, net | $4.1M | $2.5M | $1.6M | +63% |
| Income tax benefit | $219K | −$689K | $908K | — |
| Net loss | $7.7M | $14.1M | −$6.5M | -46% |
| Costs & expenses | $54.2M | $89.4M | −$35.2M | -39% |
| Operating costs | $54.2M | $88.7M | −$34.5M | -39% |
| Cost of revenue | $27.2M | $22.4M | $4.8M | +22% |
| Research & development | $4.8M | $4.9M | −$142K | -3% |
| SG&A | $22.2M | $38.7M | −$16.5M | -43% |
| Operating cash sources | $14.3M | $30.7M | −$16.5M | -54% |
| Share-based compensation | $2.1M | $6.0M | −$3.9M | -65% |
| Working capital & other | $12.2M | $24.7M | −$12.6M | -51% |
| Net loss absorbed | $7.7M | $14.1M | −$6.5M | -46% |
| Operating cash flow | $6.6M | $16.6M | −$10.0M | -60% |
Questions
How much did Amarin's revenue grow year over year in Q2 2026?
Amarin's revenue fell $30.5M (-42%) from $72.7M in Q2 2025 to $42.2M in Q2 2026.
What drove Amarin's revenue change in Q2 2026?
Licensing and Royalty −$23.0M (-88%); Product −$7.5M (-16%).